Transaction details
Gary S. Guthart, who serves on the board of Intuitive Surgical Inc (NASDAQ:ISRG), disposed of 27,300 shares of the company's common stock on January 27, 2026. The sales were completed in multiple tranches at prices spanning from $530.0981 to $531.5285, resulting in aggregate proceeds of $14,475,672.
Concurrent option exercise
On the same date, Guthart exercised stock options to obtain 25,500 shares of Intuitive Surgical common stock at an exercise price of $174.2567 per share, representing a total notional value of $4,443,545. Both the sales and the option exercise were implemented through a pre-arranged trading program compliant with SEC Rule 10b5-1. That plan is scheduled to lapse on April 28, 2026.
Quarterly performance and guidance highlights
Intuitive Surgical posted fourth-quarter 2025 revenue of $2.87 billion, a year-over-year increase of 19%, a result that topped Stifel and consensus estimates of $2.72 billion. According to commentary within analyst notes, the company beat expectations on earnings per share and revenue by roughly 11% and 4%, respectively, as observed by RBC Capital. Guidance for gross margins in 2026 was noted by Truist Securities to reflect a 90 basis point improvement compared with the prior year.
Analyst reactions
Market analysts responded to the quarterly results and company commentary with a string of positive ratings and target revisions. TD Cowen initiated coverage with a Buy rating and a $660.00 price target, identifying Intuitive Surgical as a core holding in MedTech. Freedom Capital Markets upgraded its view from Hold to Buy and set a $610.00 target, attributing its move in part to expectations tied to the da Vinci 5 surgical system rollout. Stifel and Truist Securities both maintained Buy ratings with respective price targets of $670.00 and $650.00. RBC Capital kept an Outperform rating with a $650.00 target following the quarter it described as robust.
Context and close
The insider sales and option exercise occurred alongside a quarterly report that outperformed several street estimates and prompted positive analyst activity. The trades took place under an established 10b5-1 plan, with the plan set to expire in late April 2026.